The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bender Lewis H since year 2005.
The trader's CIK number is 1238705.
At the time of this reporting, Bender Lewis H is the Chief Executive Offi of Interleukin Genetics Inc .
(stock ticker symbol ILI).
See this page for all insider trading activities at Interleukin Genetics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2008-11-21||ILI||Interleukin Genetics Inc||Buy||10,000||.27||2,700|
|2008-11-24||ILI||Interleukin Genetics Inc||Buy||20,000||.25||4,920|
|2008-11-20||ILI||Interleukin Genetics Inc||Buy||11,700||.33||3,896|
|2008-11-18||ILI||Interleukin Genetics Inc||Buy||18,300||.44||8,088|
|2008-02-19||ILI||Interleukin Genetics Inc||Buy||3,000||1.40||4,200|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bender Lewis H (Chief Executive Offi of Interleukin Genetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.